Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | 0.00% | -11.76% | -15.49% |
04-04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
02-27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-15.49% | 11.53M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.33% | 31.99B | |
+50.51% | 24.73B | |
-15.13% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.94% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Validates Safety of Drug Candidate in Phase 1 Cancer Trial